These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16515310)

  • 21. Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease.
    Schapira AH
    Neurology; 2009 Feb; 72(7 Suppl):S44-50. PubMed ID: 19221314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of early Parkinson's disease. Part 2.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):206-15. PubMed ID: 19176961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rasagiline in Parkinson's disease.
    Chahine LM; Stern MB
    Int Rev Neurobiol; 2011; 100():151-68. PubMed ID: 21971007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rasagiline in Parkinson's disease: the show must go on.
    Jost WH
    Expert Opin Drug Saf; 2013 Nov; 12(6):797-800. PubMed ID: 23909684
    [No Abstract]   [Full Text] [Related]  

  • 25. Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
    Olanow CW
    Neurology; 2009 Feb; 72(7 Suppl):S59-64. PubMed ID: 19221316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selegiline's neuroprotective capacity revisited.
    Riederer P; Lachenmayer L
    J Neural Transm (Vienna); 2003 Nov; 110(11):1273-8. PubMed ID: 14628191
    [No Abstract]   [Full Text] [Related]  

  • 27. Movement disorders: understanding clinical trials.
    Goetz CG
    Lancet Neurol; 2005 Jan; 4(1):5-6. PubMed ID: 15620847
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of Parkinson's disease. Advances in the pharmacological therapy.
    Ghika J
    Eur Neurol; 1996; 36(6):396-9. PubMed ID: 8954312
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rasagiline: effectiveness and protection in Parkinson's disease].
    Pagonabarraga J; Kulisevsky J
    Rev Neurol; 2010 Nov; 51(9):535-41. PubMed ID: 20979033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The comparative effects of medical therapies for Parkinson's disease.
    Horn S; Stern MB
    Neurology; 2004 Oct; 63(7 Suppl 2):S7-12. PubMed ID: 15477585
    [No Abstract]   [Full Text] [Related]  

  • 31. The fabulous neuroprotection of selegiline: memoir and prospectus.
    Landau WM
    J Child Neurol; 2010 Oct; 25(10):1302-4. PubMed ID: 20940135
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoamine oxidase inhibitors--is it time to up the TEMPO?
    Rascol O
    Lancet Neurol; 2003 Mar; 2(3):142-3. PubMed ID: 12849233
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.
    Jost WH; Friede M; Schnitker J
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3349. PubMed ID: 25491607
    [No Abstract]   [Full Text] [Related]  

  • 34. Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease.
    Stocchi F
    Int J Clin Pract; 2006 Feb; 60(2):215-21. PubMed ID: 16451296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Are there innovations in the treatment of Parkinson's disease?].
    Ludin HP
    Praxis (Bern 1994); 2004 Nov; 93(45):1865-8. PubMed ID: 15571301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.
    Fernandez HH; Chen JJ
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):174S-185S. PubMed ID: 18041937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rasagiline. Teva Pharmaceutical.
    Kupsch A
    Curr Opin Investig Drugs; 2002 May; 3(5):794-7. PubMed ID: 12090555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of early Parkinson's disease. Part 1.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):193-205. PubMed ID: 19176960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deprenyl--past and future. Proceedings of a symposium. Lake Starnberg, Bavaria, 1995.
    J Neural Transm Suppl; 1996; 48():1-112. PubMed ID: 9102455
    [No Abstract]   [Full Text] [Related]  

  • 40. The multiple actions of selegiline.
    Ebadi M; Sharma S; Shavali S; Sangchot P; Brekke L
    Proc West Pharmacol Soc; 2002; 45():39-41. PubMed ID: 12434521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.